<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article170</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/PROSEVA" style="display:block; margin-bottom:10px;">PROSEVA Original</a></li>
<h2><strong>PROSEVA</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Prone Positioning in Severe Acute Respiratory Distress Syndrome". The New England Journal of Medicine. 2013. 368(23):2159-2168. PubMed • Full text • PDF<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
Does the early application of prone positioning improve outcomes in patients with severe acute respiratory distress syndrome (ARDS)?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
Early application of prolonged prone-positioning sessions significantly decreased 28-day and 90-day mortality in patients with severe ARDS.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/>
Prone positioning has long been used to improve oxygenation in mechanically ventilated patients with ARDS, but previous trials failed to show survival benefits. This study demonstrated a lower mortality rate at both 28 days and 90 days in patients with ARDS and severe hypoxemia who received early application of prone positioning.<br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
Not discussed in this article.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
Multicenter, prospective, randomized, controlled trial<br/>
N=466 patients with severe ARDS<br/>
Prone group (n=237)<br/>
Supine group (n=229)<br/>
Setting: 26 ICUs in France and 1 in Spain<br/>
Enrollment: January 1, 2008, to July 25, 2011<br/>
Analysis: Intention-to-treat<br/>
Follow-up: 90 days<br/>
Primary outcome: Mortality at day 28<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Inclusion Criteria:<br/>
- Adults with ARDS as defined by the American–European Consensus Conference criteria<br/>
- Mechanical ventilation for ARDS for less than 36 hours<br/>
- Severe ARDS (PaO2:FiO2 ratio of &lt;150 mm Hg, FiO2 ≥0.6, PEEP ≥5 cm H2O, tidal volume close to 6 ml/kg of predicted body weight)<br/>
<br/>
Exclusion Criteria:<br/>
See the Supplementary Appendix of the full text article<br/>
<br/>
Baseline Characteristics:<br/>
- Similar between groups, except for SOFA score and use of neuromuscular blockers and vasopressors.<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- Prone group: Prone positioning within one hour after randomization for at least 16 consecutive hours<br/>
- Supine group: Patients remained in semirecumbent position<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcome:<br/>
- 28-day mortality: 16.0% in the prone group vs. 32.8% in the supine group (P&lt;0.001)<br/>
Secondary Outcomes:<br/>
- 90-day mortality: 23.6% in the prone group vs. 41.0% in the supine group (P&lt;0.001)<br/>
- Higher rate of successful extubation in the prone group<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- Skilled units were utilized, limiting generalizability to centers without such expertise.<br/>
- Potential imbalance due to baselines differences in SOFA score, vasopressor use, and neuromuscular blocker use.<br/>
- Higher mortality in the control group could be argued, though mortality rates were consistent with recent trials.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
Programme Hospitalier de Recherche Clinique National 2006 and 2010 of the French Ministry of Health<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
ClinicalTrials.gov number, NCT00527813
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
